Also, a study performed on malignant diseases assigned the absence or the low expression of the CYP27B1 enzyme with a poorer prognosis of the melanoma [26] and with a decreased overall survival in ovarian cancer when the enzyme was assessed as absent, respectively, or increased aggressiveness when it was assessed as low expression [47]. The gene discussed is CYP27B1; the disease is melanoma.